Literature DB >> 3986759

Immunological and biological stability of immunotoxins in vivo as studied by the clearance of disulfide-linked pokeweed antiviral protein-antibody conjugates from blood.

S Ramakrishnan, L L Houston.   

Abstract

Monoclonal antibodies against human T-cell antigen 3A1, human transferrin receptor, and mouse Thy 1.1 antigen were linked to pokeweed antiviral protein (PAP) by a disulfide bond. Because the ability of the immunotoxin to home on target cells in vivo and the eventual internalization of the hemitoxin polypeptide depends in part on the stability of the conjugate in circulation, the clearance of antibody-PAP conjugates from blood was investigated. Blood samples collected from rabbits at different times after the injection of immunotoxin were analyzed for: (a) total mouse IgG; and (b) intact antibody-PAP conjugate in enzyme-linked immunosorbent assay. Further, antibody-PAP conjugate was separated from PAP by differential precipitation using polyethyleneglycol, and the PAP content of the fractions were analyzed by radioimmunoassay. Free PAP is removed very rapidly from blood, and 95% is cleared within 2 h. Our results showed that the immunotoxin did not dissociate in circulation immediately, and about 90% of the initial concentration of the conjugate was still present for more than 4 h. Analysis by enzyme-linked immunosorbent assay showed a 4- to 8-h lag period in which immunotoxin concentrations were relatively unchanged. This was followed by a steady decline, and the half-life of the conjugate in circulation then ranged between 17 and 24 h. Not only did the immunotoxins remain intact immunologically, but they also retained their biological activity as measured by the ability of blood-borne immunotoxins to efficiently block protein synthesis of target cells in vitro. These data show that the disulfide linkage of toxin to antibody is reasonably stable and that the immunotoxin retains the biological properties of both the antibody and the hemitoxin polypeptide in circulation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3986759

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. In vivo stability of disulfide-linked immunotoxin conjugates.

Authors:  N L Letvin; V S Goldmacher; J Ritz; J M Yetz; S F Schlossman; J M Lambert
Journal:  J Clin Invest       Date:  1986-03       Impact factor: 14.808

2.  In vivo administration of lymphocyte-specific monoclonal antibodies in nonhuman primates. Delivery of ribosome-inactivating proteins to spleen and lymph node T cells.

Authors:  N L Letvin; L V Chalifoux; K A Reimann; J Ritz; S F Schlossman; J M Lambert
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

3.  Nanoconjugate based on polymalic acid for tumor targeting.

Authors:  Julia Y Ljubimova; Manabu Fujita; Natalya M Khazenzon; Bong-Seop Lee; Sebastian Wachsmann-Hogiu; Daniel L Farkas; Keith L Black; Eggehard Holler
Journal:  Chem Biol Interact       Date:  2007-02-08       Impact factor: 5.192

Review 4.  Immunotoxins against solid tumors.

Authors:  R Pirker
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

5.  An immunotoxin containing a rat IgM monoclonal antibody (Campath 1) and saporin 6: effect on T lymphocytes and hemopoietic cells.

Authors:  P L Tazzari; L Barbieri; M Gobbi; A Dinota; S Rizzi; A Bontadini; A Pession; S Tura; F Stirpe
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

6.  Monoclonal anti-human T cell antibody and PAP-s conjugate--preparation and selective cytotoxic properties on leukemic cell.

Authors:  J Y Chu; A D Yang; B M Wang; Z Hu; X M Zhu; H J Zhang; J H Qu; L Y Luo; R Guo; L R Shi
Journal:  J Tongji Med Univ       Date:  1990

Review 7.  Antibody-mediated targeting in the treatment and diagnosis of cancer: an overview.

Authors:  C H Ford; A G Casson
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Selective cytotoxic activity of immunotoxins composed of a monoclonal anti-Thy 1.1 antibody and the ribosome-inactivating proteins bryodin and momordin.

Authors:  F Stirpe; E J Wawrzynczak; A N Brown; R E Knyba; G J Watson; L Barbieri; P E Thorpe
Journal:  Br J Cancer       Date:  1988-11       Impact factor: 7.640

9.  Use of a novel colony assay to evaluate the cytotoxicity of an immunotoxin containing pokeweed antiviral protein against blast progenitor cells freshly obtained from patients with common B-lineage acute lymphoblastic leukemia.

Authors:  F M Uckun; K J Gajl-Peczalska; J H Kersey; L L Houston; D A Vallera
Journal:  J Exp Med       Date:  1986-02-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.